Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, is honored to share that it was awarded ...

It’s been a boom time for defense companies for the last few years—and the opposite of that for luxury companies. The result?

From Novo Nordisk to UnitedHealth, onetime chief executives are returning to guide their former organizations in times of ...

In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics has hired a former GLP-1 leader to steer the ship. Trine Ahlgreen is the new ...